Search Results - "Hanania, E G"

Refine Results
  1. 1
  2. 2

    Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD) by OLSSON, K, GERARD, C. J, ZEHNDER, J, JONES, C, RAMANATHAN, R, READING, C, HANANIA, E. G

    Published in Leukemia (01-11-1999)
    “…Non-Hodgkin's lymphoma (NHL) arises as a clonal transformation of normal B and T cell differentiation and is often characterized by a higher incidence of…”
    Get full text
    Conference Proceeding Journal Article
  3. 3

    Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards by GERARD, C. J, OLSSON, K, RAMANATHAN, R, READING, C, HANANIA, E. G

    Published in Cancer research (Chicago, Ill.) (01-09-1998)
    “…The complementarity determining region III of the rearranged immunoglobulin heavy chain gene has been the target for tumor-specific PCR assays for the…”
    Get full text
    Journal Article
  4. 4

    Recent advances in the application of gene therapy to human disease by Hanania, E G, Kavanagh, J, Hortobagyi, G, Giles, R E, Champlin, R, Deisseroth, A B

    Published in The American journal of medicine (01-11-1995)
    “…To review the recent advances in the application of genetic modification strategies to the therapy of human diseases for which a molecular defect is known. A…”
    Get more information
    Journal Article
  5. 5

    Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model by Hanania, E G, Deisseroth, A B

    Published in Cancer gene therapy (01-03-1994)
    “…The administration of high and repeated doses of chemotherapy has been hampered by the bone marrow toxicity imposed by these drugs. This obstacle can be…”
    Get more information
    Journal Article
  6. 6

    Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit by Hanania, E G, Fu, S, Roninson, I, Zu, Z, Deisseroth, A B

    Published in Gene therapy (01-06-1995)
    “…We used an animal model system to transplant lethally-irradiated mice with one million marrow cells which had been: (1) collected from 5-fluorouracil (5-FU)…”
    Get more information
    Journal Article
  7. 7

    Addition of the human interferon beta scaffold attachment region to retroviral vector backbones increases the level of in vivo transgene expression among progeny of engrafted human hematopoietic stem cells by Murray, L, Travis, M, Luens-Abitorabi, K, Olsson, K, Plavec, I, Forestell, S, Hanania, E G, Hill, B

    Published in Human gene therapy (20-09-2000)
    “…Absence of durable high-level expression of transgenes from Moloney murine leukemia (Mo-MuLV) retroviral vectors has been a hurdle in bringing effective gene…”
    Get more information
    Journal Article
  8. 8

    Simultaneous genetic chemoprotection of normal marrow cells and genetic chemosensitization of breast cancer cells in a mouse cancer gene therapy model by HANANIA, E. G, DEISSEROTH, A. B

    Published in Clinical cancer research (01-02-1997)
    “…Repeated exposures to high doses of chemotherapy are often required to eradicate solid tumors. The success of such high-dose therapy is often limited by the…”
    Get full text
    Journal Article
  9. 9

    Chemotherapy resistance to taxol in clonogenic progenitor cells following transduction of CD34 selected marrow and peripheral blood cells with a retrovirus that contains the MDR-1 chemotherapy resistance gene by Hanania, E G, Fu, S, Zu, Z, Hegewisch-Becker, S, Korbling, M, Hester, J, Durett, A, Andreeff, M, Mechetner, E, Holzmayer, T

    Published in Gene therapy (01-06-1995)
    “…A retrovirus containing the multiple drug resistance (MDR-1) cDNA, was used to transduce cultures of CD34 selected human marrow cells, on stromal monolayers in…”
    Get more information
    Journal Article
  10. 10

    Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML by Deisseroth, A B, Zu, Z, Claxton, D, Hanania, E G, Fu, S, Ellerson, D, Goldberg, L, Thomas, M, Janicek, K, Anderson, W F

    Published in Blood (15-05-1994)
    “…Relapse after autologous bone marrow transplantation for chronic myelogenous leukemia (CML) can be due either to the persistence of leukemia cells in systemic…”
    Get full text
    Journal Article
  11. 11

    Regulation of retinoblastoma gene expression in a mouse mammary tumor model by Hanania, E G, Au, W W, Ullrich, R L, Papaconstantinou, J

    Published in Cancer gene therapy (01-12-1995)
    “…We initiated studies to investigate the involvement of the murine retinoblastoma (RB) gene in mammary carcinogenesis using cell lines derived from mammary…”
    Get more information
    Journal Article
  12. 12

    Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells by Hu, G, Liu, W, Hanania, E G, Fu, S, Wang, T, Deisseroth, A B

    Published in Cancer gene therapy (01-03-1995)
    “…Human cervical carcinoma cell lines that harbor human papilloma virus (HPV) have been reported to express HPV E6 and E7 proteins at least in the beginning…”
    Get more information
    Journal Article
  13. 13

    Transduction of MDR1 into human and mouse haemopoietic progenitor cells: use of rhodamine (Rh123) to determine transduction frequency and in vivo selection by Hegewisch-Becker, S, Hanania, E G, Fu, S, Körbling, M, Deisseroth, A B, Andreeff, M

    Published in British journal of haematology (01-08-1995)
    “…The MDR1 gene product P-glycoprotein (P-gp) extrudes several anticancer drugs including taxol and fluorescent dyes such as rhodamine (Rh123). Modulation of the…”
    Get more information
    Journal Article
  14. 14

    PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells by Fu, S, Consoli, U, Hanania, E G, Zu, Z, Claxton, D F, Andreeff, M, Deisseroth, A B

    Published in Clinical cancer research (01-06-1995)
    “…A unique mRNA produced by the t(15;17) (q22-24;q11-21) translocation in the leukemic cells of acute promyelocytic leukemia patients encodes a chimeric protein,…”
    Get full text
    Journal Article
  15. 15

    Hematopoietic Retroviral Gene Marking in Patients with Follicular Non-Hodgkin's Lymphoma by Bachier, Carlos R., Giles, Richard E., Ellerson, Deborah, Hanania, Ellie G., Garcia-Sanchez, Felix, Andreeff, Michael, Cabanillas, Fernando, Champlin, Richard, Choudhury, Raja, Berenson, Ronald, Heimfeld, Shelly, Deisseroth, Albert B.

    Published in Leukemia & lymphoma (1999)
    “…We conducted a double retroviral vector (RV) gene marking trial to test for the possible contribution to relapse of follicular non-Hodgkin's lymphoma (FNHL)…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Molecular approaches to the diagnosis and treatment of cancer by Deisseroth, A B, Kantarjian, H, Talpaz, M, Champlin, R, Reading, C, Hanania, E G, Fu, S, Randhawa, G S, Cha, Y, Fang, X

    Published in Stem cells (Dayton, Ohio) (01-10-1993)
    “…We have used autologous bone marrow transplantation (ABMT) as a setting to develop the genetic therapy of cancer in hematopoietic neoplasms based on the use of…”
    Get more information
    Journal Article
  19. 19

    Optoinjection for efficient targeted delivery of a broad range of compounds and macromolecules into diverse cell types by Clark, Imran B, Hanania, Elie G, Stevens, Janine, Gallina, Marijo, Fieck, Annabeth, Brandes, Rolf, Palsson, Bernhard O, Koller, Manfred R

    Published in Journal of biomedical optics (01-01-2006)
    “…Efficient delivery of compounds and macromolecules into living cells is essential in many fields including basic research, applied drug discovery, and clinical…”
    Get more information
    Journal Article
  20. 20

    High‐throughput laser‐mediated in situ cell purification with high purity and yield by Koller, Manfred R., Hanania, Elie G., Stevens, Janine, Eisfeld, Timothy M., Sasaki, Glenn C., Fieck, Annabeth, Palsson, Bernhard Ø.

    Published in Cytometry. Part A (01-10-2004)
    “…Background Technologies for purification of living cells have significantly advanced basic and applied research in many settings. Nevertheless, certain…”
    Get full text
    Journal Article